COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,284 Articles (22,759 medRxiv, 8,525 bioRxiv)

Most recent first Previous |  Page 580: Articles 5791-5800  | Next

Cohort profile: A Quebec-based plasma donor biobank to study COVID-19 immunity (PlasCoV)
Germain, M., Lewin, A., Bazin, R., Dieude, M., Perreault, J., Boivin, A., Gregoire, Y., Renaud, C.
10.1101/2022.11.09.22282156 — Posted: 2022-11-11
Assessing the spatial-temporal risks of SARS-CoV-2 infection for healthcare-workers in the hospital using behavioural indices from routine data
Wilson-Aggarwal, J., Gotts, N., Arnold, K., Spyer, M. J., Houlihan, C., Nastouli, E., Manley, E.
10.1101/2022.11.10.22282176 — Posted: 2022-11-11
A Tale of Two Waves: Diverse Genomic and Transmission Landscapes Over 15 Months of the COVID-19 Pandemic in Pune, India
Niveditha, D., Khan, S., Khilari, A., Nadkarni, S., Bhalerao, U., Kadam, P., Yadav, R., Kanekar, J., Shah, N., Likhitkar, B., Sawant, R., Thakur, S., Tupekar, M., nagar, D., Rao, A., Jagtap, R., Jogi, S., Belekar, M., Pathak, M., Shah, P., Ranade, S., Phadke, N., Das, R., Joshi, S., Karyakarte, R. P., Ghose, A., Kadoo, N., Shashidhara, L., Monteiro, J. M., Shanmugam, D., Raghunathan, A., Karmodiya, K.
10.1101/2022.11.05.22281203 — Posted: 2022-11-11
Identification of small molecules with virus growth enhancement properties
Garcia-Murria, M. J., Gadea-Salom, L., Moreno, S., Zaragoza, O., Brun, A., Mingarro, I., Martinez-Gil, L.
10.1101/2022.11.08.515589 — Posted: 2022-11-10
Precise identification of cell states altered indisease with healthy single-cell references
Dann, E., Teichmann, S., Marioni, J.
10.1101/2022.11.10.515939 — Posted: 2022-11-10
An intranasal self-amplifying RNA SARS-CoV-2 vaccine produces durable respiratory and systemic immunity
Jennewein, M. F., Beaver, S., Battisti, P., Bakken, J., Hanson, D., Mohamath, R., Singh, J., Cross, N., Reed, S., Gerhardt, A., Casper, C., Voigt, E. A.
10.1101/2022.11.10.515993 — Posted: 2022-11-10
Evasive spike variants elucidate the preservation of T cell immune response to the SARS-CoV-2 omicron variant
Solanki, A., Cornette, J., Udell, J., Vasmatzis, G., Riedel, M.
10.1101/2022.11.04.515139 — Posted: 2022-11-10
Assessing the Effect of Selective Serotonin Reuptake Inhibitors in the Prevention of Post-Acute Sequelae of COVID-19
Sidky, H., Sahner, D. K., Girvin, A. T., Hotaling, N., Michael, S. G., Kurilla, M. G., Gersing, K., The N3C consortium
10.1101/2022.11.09.22282142 — Posted: 2022-11-10
Galectin approach to lower covid transmission - Drug Development for clinical use
Sigamani, A., Mayo, K. H., Chen-Walden, H., Reddy, S., Platt, D.
10.1101/2022.11.09.22282151 — Posted: 2022-11-10
The role of cholesterol metabolism in predicting clinical outcome of patients with severe COVID-19
Usenko, T., Miroshnikova, V., Bezrukova, A., Basharova, K., Landa, S., Korobova, Z., Liubimova, N., Vlasov, I., Nikolaev, M., Izyumchenko, A., Gavrilova, E., Shlyk, I., Chernitskaya, E., Kovalchuk, Y., Slominsky, P., Totolian, A., Polushin, Y., Pchelina, S.
10.1101/2022.11.10.22282185 — Posted: 2022-11-10

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).